Predicting risk factors for hypothyroidism after definitive radiotherapy for early glottic carcinomas

被引:0
|
作者
Okubo, Mitsuru [1 ,3 ]
Itonaga, Tomohiro [1 ]
Saito, Tatsuhiko [1 ]
Yunaiyama, Daisuke [1 ]
Mikami, Ryuji [1 ]
Okada, Yukinori [1 ]
Sugahara, Shinji [1 ]
Kondo, Takahito [2 ]
Tokuuye, Koichi [1 ]
Saito, Kazuhiro [1 ]
机构
[1] Tokyo Med Univ Hosp, Dept Radiol, Tokyo 1600023, Japan
[2] Tokyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Hachioji Med Ctr, Tokyo 1930998, Japan
[3] Tokyo Med Univ Hosp, Dept Radiol, 6-7-1 Nishishinjuku, Tokyo, Tokyo 1600023, Japan
关键词
glottic carcinomas; hypothyroidism; laryngeal carcinoma; radiotherapy; thyroid gland; RADIATION-INDUCED HYPOTHYROIDISM; NECK-CANCER-PATIENTS; SUBCLINICAL HYPOTHYROIDISM; DOSIMETRIC PREDICTORS; HEAD; THERAPY;
D O I
10.3892/ol.2022.13603
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hypothyroidism may occur after definitive radiotherapy in rare cases of early glottic carcinoma. However, to the best of our knowledge, no study to date has examined the risk factors for hypothyroidism specifically after definitive radiotherapy in patients with early glottic carcinoma. The present study determined risk factors for hypothyroidism after definitive radiotherapy in patients with early glottic carcinoma. This was a retrospective study that included 73 patients with T1 or T2, N0 glottic squamous cell carcinoma who underwent radiotherapy between June 3, 2009 and December 25, 2020. Demographic and clinical characteristics, including age, sex, tumor stage and pretreatment thyroid volume, were examined to elucidate the clinical risk factors for hypothyroidism. Field size, total prescribed dose and thyroid receiving dose were evaluated as dosimetric risk factors for hypothyroidism. Irradiated underlying thyroid volumes of more than 5, 10, 20, 30, 40, 50, 60 and 65 Gy (V5Gy, V10Gy, V20Gy, V30Gy, V40Gy, V50Gy, V60Gy and V65Gy) and mean thyroid dose were included as thyroid receiving doses. The median follow-up duration was 61 months (range, 7-150 months). Hypothyroidism was present in 15 (21%) of the 73 patients, including 12 and 3 patients with grade 1 and 2 hypothyroidism, respectively. Among the demographic and clinical factors, sex and pretreatment thyroid volume were significantly associated with hypothyroidism (P=0.007 and P<0.001, respectively). Among the dosimetric factors, the presence of hypothyroidism was significantly associated with V5Gy (P=0.012), V10Gy (P=0.015), V20Gy (P=0.020), V30Gy (P=0.024), V40Gy (P=0.028), V50Gy (P=0.028), V60Gy (P=0.027) and mean thyroid dose (P=0.023). In conclusion, sex, pretreatment thyroid volume and thyroid receiving dose were associated with hypothyroidism after definitive radiotherapy in patients with early glottic carcinoma. Particularly, the receiving dose to the thyroid gland should be reduced in female patients and in those with small thyroid volumes who are at higher risk for hypothyroidism following radiotherapy.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Predictive factors for local control of early glottic squamous cell carcinomas after definitive radiotherapy
    Okubo, Mitsuru
    Itonaga, Tomohiro
    Saito, Tatsuhiko
    Shiraishi, Sachika
    Mikami, Ryuji
    Sakurada, Akira
    Sugahara, Shinji
    Park, Jinho
    Tokuuye, Koichi
    Saito, Kazuhiro
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2020, 12 (06) : 541 - 550
  • [2] Risk factors for voice quality after radiotherapy for early glottic cancer
    Hocevar-Boltezar, Irena
    Zargi, Miha
    Strojan, Primoz
    [J]. RADIOTHERAPY AND ONCOLOGY, 2009, 93 (03) : 524 - 529
  • [3] Definitive radiotherapy for early glottic carcinoma: Prognostic factors and implications for treatment
    Burke, LS
    Greven, KM
    McGuirt, WT
    Case, D
    Hoen, HM
    Raben, M
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 38 (01): : 37 - 42
  • [4] Definitive radiotherapy for early glottic carcinoma: Prognostic factors and implications for treatment
    Burke, LS
    Greven, KM
    McGuirt, WT
    Case, D
    Hoen, HM
    Raben, M
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 38 (05): : 1001 - 1006
  • [5] EARLY GLOTTIC CARCINOMA - PATTERNS AND PREDICTORS OF RELAPSE AFTER DEFINITIVE RADIOTHERAPY
    KERSH, CR
    KELLY, MD
    HAHN, SS
    SPAULDING, CA
    CANTRELL, RW
    CONSTABLE, WC
    [J]. SOUTHERN MEDICAL JOURNAL, 1990, 83 (04) : 374 - 378
  • [6] Voice Quality After Radiotherapy and Cordectomy in Early-Stage Glottic Carcinomas
    Mehel, Dursun Mehmet
    Ozgur, Abdulkadir
    Sahin, Nilgun
    Vural, Asli Aybuke
    Yemis, Tugba
    Celebi, Mehmet
    Aydemir, Samet
    Ozdemir, Dogukan
    Akgul, Gokhan
    [J]. ENT-EAR NOSE & THROAT JOURNAL, 2021, 100 (04) : NP173 - NP176
  • [7] Surgery or radiotherapy for early stages carcinomas of the glottic larynx
    Magnano, M
    Cavalot, AL
    Gervasio, CF
    Lerda, W
    Gabriele, P
    Orecchia, R
    Ruo-Redda, MG
    Beltramo, G
    Ragona, R
    Cortesina, G
    [J]. TUMORI, 1999, 85 (03) : 188 - 193
  • [8] Risk factors of early thyroid dysfunction after definitive radiotherapy in nasopharyngeal carcinoma patients
    Lian, Chen-Lu
    Zhuo, Ren-Gong
    Zhou, Rui
    Yu, Yi-Feng
    Zhou, Ping
    Lin, Qin
    Wu, San-Gang
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2023, 45 (09): : 2344 - 2354
  • [9] Definitive radiotherapy for early stage glottic cancer by 6 MV photons
    Tong, Chi-Chung
    Au, Kwok-Hung
    Ngan, Roger Kai-Cheong
    Cheung, Foon-Yiu
    Chow, Sin-Ming
    Fu, Yiu-Tung
    Au, Joseph Siu-Kei
    Law, Stephen Chun-Key
    [J]. HEAD & NECK ONCOLOGY, 2012, 4
  • [10] Factors affecting voice quality in early glottic cancer before and after radiotherapy
    Mekis, Jana
    Strojan, Primoz
    Boltezar, Irena Hocevar
    [J]. RADIOLOGY AND ONCOLOGY, 2019, 53 (04) : 459 - 464